Gemcitabine Plus Bevacizumab Compared With Gemcitabine Plus Placebo in Patients With Advanced Pancreatic Cancer: Phase III Trial of the Cancer and Leukemia Group B (CALGB 80303)Hedy L. Kindler, Richard M. Goldberg, Robert J. Mayer et al.|Journal of Clinical Oncology|2010Cited by 840
Pertuzumab plus trastuzumab for HER2-amplified metastatic colorectal cancer (MyPathway): an updated report from a multicentre, open-label, phase 2a, multiple basket studyFunda Meric‐Bernstam, John D. Hainsworth, Herbert I. Hurwitz et al.|The Lancet Oncology|2019Cited by 564
Efficacy and Safety of Bevacizumab in Metastatic Colorectal Cancer: Pooled Analysis From Seven Randomized Controlled TrialsHerbert I. Hurwitz, Josep Tabernero, Fairooz F. Kabbinavar et al.|The Oncologist|2013Cited by 235
Response-Independent Survival Benefit in Metastatic Colorectal Cancer: A Comparative Analysis of N9741 and AVF2107Axel Grothey, Daniel J. Sargent, Eric Hedrick et al.|Journal of Clinical Oncology|2008Cited by 171
Effect of bevacizumab in older patients with metastatic colorectal cancer: pooled analysis of four randomized studiesJames T. Cassidy, Ulrich‐Peter Rohr, Leonard B. Saltz et al.|Journal of Cancer Research and Clinical Oncology|2009Cited by 160